{"status": "Ok", "redirect_url": "https://www.businesswire.com/news/home/20260805331090/en/U.S.-FDA-Accepts-sBLA-for-ENFLONSIA%E2%84%A2-clesrovimab-cfor-to-Update-its-Respiratory-Syncytial-Virus-RSV-Lower-Respiratory-Tract-Disease-Indication-to-Include-Children-Under-Two-Years-at-Increased-Risk-for-Severe-RSV-for-Their-Second-Season", "message": "News view counter 867890 successfully enlarged"}